These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inflammasome activation: from inflammatory disease to infection. Dunne A. Biochem Soc Trans; 2011 Apr; 39(2):669-73. PubMed ID: 21428959 [Abstract] [Full Text] [Related]
4. The inflammasomes in kidney disease. Anders HJ, Muruve DA. J Am Soc Nephrol; 2011 Jun; 22(6):1007-18. PubMed ID: 21566058 [Abstract] [Full Text] [Related]
9. Inflammasome activation and metabolic disease progression. Li HB, Jin C, Chen Y, Flavell RA. Cytokine Growth Factor Rev; 2014 Dec; 25(6):699-706. PubMed ID: 25156419 [Abstract] [Full Text] [Related]
10. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Church LD, Cook GP, McDermott MF. Nat Clin Pract Rheumatol; 2008 Jan; 4(1):34-42. PubMed ID: 18172447 [Abstract] [Full Text] [Related]
11. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. McDermott MF, Tschopp J. Trends Mol Med; 2007 Sep; 13(9):381-8. PubMed ID: 17822957 [Abstract] [Full Text] [Related]
12. NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium. Sokolova M, Ranheim T, Louwe MC, Halvorsen B, Yndestad A, Aukrust P. J Cardiovasc Pharmacol; 2019 Oct; 74(4):276-284. PubMed ID: 31584530 [Abstract] [Full Text] [Related]
17. IL-1beta processing in host defense: beyond the inflammasomes. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. PLoS Pathog; 2010 Feb 26; 6(2):e1000661. PubMed ID: 20195505 [Abstract] [Full Text] [Related]
20. The inflammasomes: guardians of the body. Martinon F, Mayor A, Tschopp J. Annu Rev Immunol; 2009 Feb 26; 27():229-65. PubMed ID: 19302040 [Abstract] [Full Text] [Related] Page: [Next] [New Search]